Chemoinformaics analysis of 1,4-CYCLOHEXADIENE
Molecular Weight | 80.13 | nRot | 0 |
Heavy Atom Molecular Weight | 72.066 | nRig | 6 |
Exact Molecular Weight | 80.0626 | nRing | 1 |
Solubility: LogS | -2.152 | nHRing | 0 |
Solubility: LogP | 2.549 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 14 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 15.3543 |
nHD | 0 | BPOL | 8.02566 |
QED | 0.39 |
Synth | 3.509 |
Natural Product Likeliness | 1.34 |
NR-PPAR-gamma | 0.152 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.002 |
HIA | 0.005 |
CACO-2 | -4.366 |
MDCK | 0.0000317 |
BBB | 0.959 |
PPB | 0.518393 |
VDSS | 2.099 |
FU | 0.379672 |
CYP1A2-inh | 0.855 |
CYP1A2-sub | 0.285 |
CYP2c19-inh | 0.145 |
CYP2c19-sub | 0.186 |
CYP2c9-inh | 0.021 |
CYP2c9-sub | 0.806 |
CYP2d6-inh | 0.023 |
CYP2d6-sub | 0.639 |
CYP3a4-inh | 0.116 |
CYP3a4-sub | 0.146 |
CL | 13.65 |
T12 | 0.742 |
hERG | 0.003 |
Ames | 0.958 |
ROA | 0.019 |
SkinSen | 0.949 |
Carcinogencity | 0.807 |
EI | 0.995 |
Respiratory | 0.836 |
NR-Aromatase | 0.007 |
Antiviral | No |
Prediction | 0.937152 |